Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 10.26 EX-10.26 First Amendment to Employment Agreement by and Between Archemix Corp. and Errol De Souza, Dated June 30, 2008
- 10.31 EX-10.31 Form of Change In Control Agreement
- 10.33 EX-10.33 Amended and Restated Collaboration Agreement by and Between Archemix Corp. and Nuvelo, Inc., Dated July 31, 2006
- 10.34 EX-10.34 Collaborative Research and License Agreement by and Between Archemix Corp. and Merck Kgaa, Dated January 17, 2007, As Amended June 6, 2007
- 10.35 EX-10.35 Collaborative Research and License Agreement Between Archemix Corp. and Merck Kgaa, Dated As of June 6, 2007 2007, As Amended June 6, 2007
- 10.36 EX-10.36 License Agreement Between Gilead Sciences, Inc. and Archemix Corp., Dated As of October 23, 2001
- 10.37 EX-10.37 Settlement Agreement and Release by and Among Archemix Corp., Gilead Sciences, Inc. and University License Equity Holdings, Inc., Dated September 4, 2003
- 10.38 EX-10.38 Amended and Restated License Agreement by and Between Archemix Corp. and Somalogic, Inc., Dated As of June 14, 2007
- 10.39 EX-10.39 License Agreement by and Between Archemix Corp. and Regado Biosciences, Inc., Dated As of October, 2003
- 10.40 EX-10.40 Collaborative Research and License Agreement by and Between Archemix Corp. and Takeda Pharmaceutical Company Limited, Dated June 11, 2007
- 10.41 EX-10.41 Collaborative Research and License Agreement by and Between Archemix Corp. and Elan Pharma International Limited, Dated June 30, 2006
- 10.42 EX-10.42 Collaborative Research, Services and License Agreement by and Between Archemix Corp. and Pfizer Inc., Dated As of December 21, 2006
- 10.43 EX-10.43 Technology Development and License Agreement by and Between Archemix Corp. and Aptamera, Inc. (Now Known As Antisoma PLC), Dated As of August 6, 2003
- 10.44 EX-10.44 Research and License Agreement by and Between Archemix Corp. and Eyetech Pharmaceuticals, Inc. (Now Known As Osi Pharmaceuticals, Inc.), Dated As of April 8, 2004
- 10.45 EX-10.45 License Agreement by and Between Archemix Corp. and Isis Pharmaceuticals, Inc., Dated As of July 23, 2007
- 10.46 EX-10.46 Exclusive License Agreement by and Between Archemix Corp. and Ophthotech Corporation, Dated As of July 31, 2007
- 10.47 EX-10.47 Feasibility Study, License and Option Agreement by and Between Archemix Corp. and Eli Lilly and Company, Dated As of August 31, 2008
- 10.48 EX-10.48 Exclusive License Agreement by and Between Archemix Corp. and Ribomic, Inc., Dated Effective As of December 10, 2007, As Amended on June 11, 2008
- 10.49 EX-10.49 Research License and Option Agreement by and Between Archemix Corp. and Ribomic, Inc., Dated Effective As of June 11, 2008
- 10.51 EX-10.51 Amdned and Restated 2001 Employee Director and Consultant Stock Plan
- 21.1 EX-21.1 Subsidiaries of Nitromed, Inc.
- 23.2 EX-23.2 Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm of Nitromed, Inc.
- 23.3 EX-23.3 Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm of Archemix Corp.
- 99.1 EX-99.1 Form of Proxy Card for Holders of Nitromed's Common Stock
- 99.2 EX-99.2 Consent of Cowen and Company, LLC
- 99.6 EX-99.6 Consent of Errol De Souza, PH.D. to Be Named As a Director
- 99.7 EX-99.7 Consent of Alex Barkas, PH.D. to Be Named a Director
- 99.8 EX-99.8 Consent of Peter Barrett, PH.D. to Be Named a Director
- 99.9 EX-99.9 Consent of John Maraganore PH.D. to Be Named a Director
- 99.10 EX-99.10 Consent of Michael Ross, PH.D. to Be Named a Director
Filing view
External links
Exhibit 99.8
CONSENT OF PROSPECTIVE DIRECTOR
The undersigned hereby consents to being named in the Registration Statement on Form S-4 filed by NitroMed, Inc. (“NitroMed”), and the Joint Proxy Statement/Prospectus contained therein, as a person who will serve as a director of NitroMed following completion of the merger of Newport Acquisition Corp. with and into Archemix Corp.
December 18, 2008 | /s/ Peter Barrett, Ph.D. | |||
Peter Barrett, Ph.D. | ||||